These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16873939)

  • 41. Recent Developments in the Role of Coenzyme Q10 for Coronary Heart Disease: a Systematic Review.
    Ayers J; Cook J; Koenig RA; Sisson EM; Dixon DL
    Curr Atheroscler Rep; 2018 May; 20(6):29. PubMed ID: 29766349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CoQ10 and L-carnitine for statin myalgia?
    DiNicolantonio JJ
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1329-33. PubMed ID: 23190071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Statin intolerance].
    Graversen CB; Larsen ML; Schmidt EB
    Ugeskr Laeger; 2015 Aug; 177(36):. PubMed ID: 26324293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Considerations for supplementing with coenzyme Q10 during statin therapy.
    Levy HB; Kohlhaas HK
    Ann Pharmacother; 2006 Feb; 40(2):290-4. PubMed ID: 16449543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statin cardiomyopathy? A potential role for Co-Enzyme Q10 therapy for statin-induced changes in diastolic LV performance: description of a clinical protocol.
    Silver MA; Langsjoen PH; Szabo S; Patil H; Zelinger A
    Biofactors; 2003; 18(1-4):125-7. PubMed ID: 14695927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M; Corsini A; Roden M
    Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Simard C; Poirier P
    Can J Cardiol; 2006 Feb; 22(2):141-4. PubMed ID: 16485049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statin induced myopathy.
    Frank RE
    J Insur Med; 2009; 41(2):132-5. PubMed ID: 19845216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications.
    Langsjoen PH; Langsjoen AM
    Biofactors; 2003; 18(1-4):101-11. PubMed ID: 14695925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey.
    Jacobson TA; Khan A; Maki KC; Brinton EA; Cohen JD
    J Clin Lipidol; 2018; 12(1):78-88. PubMed ID: 29239815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy.
    Bogsrud MP; Langslet G; Ose L; Arnesen KE; Sm Stuen MC; Malt UF; Woldseth B; Retterstøl K
    Scand Cardiovasc J; 2013 Apr; 47(2):80-7. PubMed ID: 23301875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reversible myopathy after statin therapy in patients with normal creatine kinase levels.
    Bennett WE; Drake AJ; Shakir KM
    Ann Intern Med; 2003 Mar; 138(5):436-7. PubMed ID: 12614104
    [No Abstract]   [Full Text] [Related]  

  • 57. Statin-associated adverse cognitive effects: survey results from 171 patients.
    Evans MA; Golomb BA
    Pharmacotherapy; 2009 Jul; 29(7):800-11. PubMed ID: 19558254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does Coenzyme Q10 Supplementation Mitigate Statin-Associated Muscle Symptoms? Pharmacological and Methodological Considerations.
    Taylor BA
    Am J Cardiovasc Drugs; 2018 Apr; 18(2):75-82. PubMed ID: 29027135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coenzyme Q(10) and selenium in statin-associated myopathy treatment.
    Fedacko J; Pella D; Fedackova P; Hänninen O; Tuomainen P; Jarcuska P; Lopuchovsky T; Jedlickova L; Merkovska L; Littarru GP
    Can J Physiol Pharmacol; 2013 Feb; 91(2):165-70. PubMed ID: 23458201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats.
    Abdelbaset M; Safar MM; Mahmoud SS; Negm SA; Agha AM
    Can J Physiol Pharmacol; 2014 Jun; 92(6):481-9. PubMed ID: 24896301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.